期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
多通道升降沿产生激光驱动器超窄脉冲新方法 被引量:1
1
作者 韩翰 耿林 吕伟强 《激光与红外》 CAS CSCD 北大核心 2022年第11期1629-1634,共6页
应用于不同领域的超窄脉冲激光驱动器要求输入脉冲宽度极窄,并且大范围内可调。传统的模拟器件可调性差难以满足要求,数字器件例如专用集成电路(ASIC)尽管脉冲宽度可以实现超窄输出,但是大范围内可调不易满足,并且存在可扩展性差,价格... 应用于不同领域的超窄脉冲激光驱动器要求输入脉冲宽度极窄,并且大范围内可调。传统的模拟器件可调性差难以满足要求,数字器件例如专用集成电路(ASIC)尽管脉冲宽度可以实现超窄输出,但是大范围内可调不易满足,并且存在可扩展性差,价格昂贵等特点,同样不利于推广。现场可编程门阵列(FPGA)程控性好,因此在脉冲激光驱动器中的数字脉冲源得到了很好的应用,但是传统的计数方法只能实现脉宽为时钟周期倍数的脉冲输出,因此只能应用于对窄脉宽要求不高的情形。为解决上述问题,本文基于FPGA设计了一种应用于超窄脉冲激光驱动器,在50 MHz时钟频率下利用锁相环倍频成多个通道的基准时钟,并分别利用上升下降沿计数器进行计数,再经不同逻辑运算输出的数字脉冲产生方法。最终的数字电路可以产生脉宽2~50 ns,步长1 ns可调,重复频率1 Hz~1 MHz的数字脉冲信号。最后分析了在高精度锁相环等硬件条件满足的情况下,该方法可以实现亚纳秒脉宽和步长的数字脉冲信号输出,因此具备了很好的可拓展性和前景。 展开更多
关键词 超窄脉冲激光驱动器 现场可编程门阵列(FPGA) 多通道上升下降沿计数器
下载PDF
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
2
作者 Wenxian Wang Bin Lian +133 位作者 Chunwei Xu Qian Wang Ziming Li Nan Zheng Aijun Liu Jinpu Yu Wenzhao Zhong Zhijie Wang Yongchang Zhang Jingjing Liu Shirong Zhang Xiuyu Cai Anwen Liu Wen Li Lili Mao Ping Zhan Hongbing Liu Tangfeng Lv Liyun Miao lingfeng Min Yu Chen Jingping Yuan Feng Wang Zhansheng Jiang gen lin Long Huang Xingxiang Pu Rongbo lin Weifeng Liu Chuangzhou Rao Dongqing Lv Zongyang Yu Xiaoyan Li Chuanhao Tang Chengzhi Zhou Junping Zhang Junli Xue Hui Guo Qian Chu Rui Meng Xuewen Liu Jingxun Wu Rui Zhang Jin Zhou Zhengfei Zhu Yongheng Li Hong Qiu Fan Xia Yuanyuan Lu Xiaofeng Chen Jian Feng Rui Ge Enyong Dai Yu Han Weiwei Pan Fei Pang Xin Huang Meizhen Hu Qing Hao Kai Wang Fan Wu Binbin Song Bingwei Xu Liping Wang Youcai Zhu Li lin Yanru Xie Xinqing lin Jing Cai ling Xu Jisheng Li Xiaodong Jiao Kainan Li Jia Wei Huijing Feng lin Wang Yingying Du Wang Yao Xuefei Shi Xiaomin Niu Dongmei Yuan Yanwen Yao Jianhui Huang Yue Feng Yinbin Zhang Pingli Sun Hong Wang Mingxiang Ye Dong Wang Zhaofeng Wang Yue Hao Zhen Wang Bin Wan Donglai Lv Shengjie Yang Jin Kang Jiatao Zhang Chao Zhang Wenfeng Li Jianfei Fu Lizhi Wu Shijie Lan Juanjuan Ou lin Shi Zhanqiang Zhai Yina Wang Bihui Li Zhang Zhang Ke Wang Xuelei Ma Zhongwu Li Zhefeng Liu Nong Yang lin Wu Huijuan Wang Gu Jin Guansong Wang Jiandong Wang Hubing Shi Meiyu Fang Yong Fang Yuan Li Xiaojia Wang Jing Chen Yiping Zhang Xixu Zhu Yi Shen Shenglin Ma Biyun Wang Yong Song Zhengbo Song Wenfeng Fang Yuanzhi Lu Lu Si 《The Innovation》 EI 2024年第6期100-116,共17页
The BRAF gene is an important signaling molecule in human cells that is involved in the regulation of cell growth,differentiation,and survival.When the BRAF gene mutates,it can lead to abnormal activation of the signa... The BRAF gene is an important signaling molecule in human cells that is involved in the regulation of cell growth,differentiation,and survival.When the BRAF gene mutates,it can lead to abnormal activation of the signaling pathway,which promotes cell proliferation,inhibits cell apoptosis,and ultimately contributes to the occurrence and development of cancer.BRAF mutations are widely present in various cancers,including malignant melanoma,thyroid cancer,colorectal cancer,non-small cell lung cancer,and hairy cell leukemia,among others.BRAF is an important target for the treatment of various solid tumors,and targeted combination therapies,represented by BRAF inhibitors,have become one of the main treatment modalities for a variety of BRAF-mutation-positive solid tumors. 展开更多
关键词 BRAF DIAGNOSIS TREATMENT
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部